Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$49.79 - $68.85 $896 - $1,239
18 Added 0.02%
91,084 $6.24 Million
Q1 2024

May 01, 2024

SELL
$51.15 - $56.52 $49,155 - $54,315
-961 Reduced 1.04%
91,066 $4.88 Million
Q4 2023

Jan 26, 2024

SELL
$43.79 - $55.14 $781,563 - $984,138
-17,848 Reduced 16.24%
92,027 $4.9 Million
Q3 2023

Nov 13, 2023

BUY
$49.1 - $62.37 $10,556 - $13,409
215 Added 0.2%
109,875 $5.46 Million
Q2 2023

Jul 28, 2023

SELL
$52.61 - $59.54 $22,937 - $25,959
-436 Reduced 0.4%
109,660 $6.53 Million
Q1 2023

May 03, 2023

BUY
$51.83 - $79.63 $2.49 Million - $3.83 Million
48,109 Added 77.61%
110,096 $6.24 Million
Q4 2022

Jan 24, 2023

SELL
$58.4 - $75.53 $122,056 - $157,857
-2,090 Reduced 3.26%
61,987 $4.6 Million
Q2 2022

Aug 08, 2022

BUY
$53.08 - $81.37 $3.4 Million - $5.21 Million
64,077 New
64,077 $3.6 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.